Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders

NCT03855631 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03855631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03855631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
September 28, 2020
Completion date
November 27, 2020
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kabuki syndrome 1